MESOCAÏNE 50 mg/5 ml, solution for injection ampoule, 5 ml
Active ingredients: Lidocaine hydrochloride
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injectionampoule, 5 mlinfiltration;intraarticulaire;périarticulaire;péridurale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- MESOCAÏNE 50 mg/5 ml, solution injectable
- Pharmaceutical form
- solution injectable
- Route of administration
- infiltration;intraarticulaire;périarticulaire;péridurale
- Presentation description
- 1 ampoule(s) bouteille en verre autocassable de 5 ml
- Marketing authorisation holder
- LABORATOIRES ETHYPHARM
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 19 Feb 1991
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63572616CIP73310801CIP133400933108014Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| LIDOCAÏNE (CHLORHYDRATE DE)solution | 50 mg · 5 ml | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.